| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cytarabine | dna polymerase beta | small molecule | NA | drugbank , DGIDB | Leukemia Myelocytic Acute[MeSHID:D015470] Blast Phase[MeSHID:D001752] Diagnosis[MeSHID:D003933] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.04 | approved,investigational | inhibitor |
| cytarabine | dna | small molecule | NA | drugbank | Leukemia Myelocytic Acute[MeSHID:D015470] Blast Phase[MeSHID:D001752] Diagnosis[MeSHID:D003933] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | cross-linking/alkylation |
| click here to return to the previous page | ||||||||